EBMT-EHA 8th European CAR T-cell Meeting

The EBMT and EHA are excited to announce the eighth edition of the jointly organised European CAR T-cell Meeting.

Dates: 12-14 February 2026
Location: Palma de Mallorca, Spain
Format: Hybrid
Chairs: Annalisa Ruggeri and Maria Themeli

To find out how you can take part, visit our registration page.

Promotional image for the 8th European CAR T-cell Meeting | Text: 12–14 February 2026, 8th European CAR T-cell Meeting, Palma de Mallorca, Spain

The promise of directing the immune system to precisely target malignancies is extraordinary, and clinical successes inspire for broader application. Yet, the path from concept to clinical reality remains complex, with challenges in manufacturing, delivery, long-term efficacy and safety.This meeting will bring together key opinion leaders, experts, and stakeholders to navigate through the evolving landscape of CAR T therapies, focusing on:

  • Clinical successes and challenges
  • The management of toxicities
  • Mechanisms and strategies for long-term safety and efficacy
  • Recent scientific innovations and new indications

Building on the success of previous editions, the upcoming meeting will feature a comprehensive program showcasing the latest

  • Scientific advances
  • Clinical developments
  • Real-world applications

We look forward to insightful discussions, meaningful connections, and continued progress in advancing patient care.

For those unable to attend in-person, the meeting will also be available virtually, with most of the sessions livestreamed via the virtual meeting platform.

Whether you’re a physician, scientist, industry representative, nurse, data manager, pharmacist, or patient advocate, this meeting offers a unique opportunity to engage with the forefront of CAR T-cell therapy development.

Format

This is a hybrid meeting, which can be attended in person or virtually.

The emphasis lies on in-person participation in the program, but most sessions will be live-streamed via a virtual platform for those who can only follow the program remotely.

Target audience

The target audience is:

  • Hematologists
  • Oncologists
  • Physicians
  • Nurses
  • Data managers
  • Supply chain managers
  • Patient organisation representatives

Program

The meeting is led by Annalisa Ruggeri and Maria Themeli, in close collaboration with the Scientific Program Committee (SPC). Together, they’ve created the program and helped to select speakers.

The members are:

  • Raffaella Greco (Italy)
  • Stephan Mielke (Sweden)
  • Natacha Bolaños (Spain)
  • Alex Rampotas (United Kingdom)
  • Julio Delgado (Spain)
  • Ulrike Köhl (Germany)
  • Mairéad Ni Chonghaile (Ireland)
  • Jürgen Kuball (The Netherlands)
  • Koray Yalcin (Türkiye)
  • Chiara Bonini (Italy)
  • Hilda Mekelenkamp (The Netherlands)
  • Jana Pelouchova (Czech Republic)

You can find out more about individual sessions by viewing the online meeting program.

You can also download the document version of the meeting program (PDF, 343 KB).

EBAH-CME accreditation

Continuing Medical Education (CME) is widely accepted to encourage individual practitioners to:

  • Maintain and develop professional knowledge and skills
  • Keep up to date with the latest developments within the field

The meeting will be accredited by the EBAH system.

Under this system, participants of this meeting are eligible to receive one CME credit point for every hour of accredited activity.

In order to collect your EBAH-CME credits, we recommend you create an EBAH-CME account.

By registering on the EBAH-CME website, you can access a record of accreditations you’ve received for previous events.

EBAH 'CME-accredited' stamp

Share